摘要 :
Background: The spectrum of heart diseases varies between and within countries, depending on the stage of epidemiological transition and risk factor profiles, understanding this spectrum requires regional and national data for eac...
展开
Background: The spectrum of heart diseases varies between and within countries, depending on the stage of epidemiological transition and risk factor profiles, understanding this spectrum requires regional and national data for each region and country. Objective: To assess the spectrum of heart diseases in Sanaa, the Capital of Yemen republic. Methods: This retrospective, descriptive registry reviewed abnormal echocardiographic findings of 6044 patients aged 0 - 100 years, (3264 male patients (54%), and 2780 female patients (46%) from January 2019 to May 2022. Results: Hypertensive heart disease (HHD) (n: 1597, 26.42%), valvular heart disease (VHD) (n: 1356, 22.44%), heart failure with reduced ejection fraction (HFrEF) (n: 1189, 19.67%) and Ischemic heart disease (I.H.D) (n: 1027, 16.99%) were the most frequent comorbidities. Congenital heart diseases (CHDs) were detected in 123 (2%) of the patients, with the most common ones including atrial septal defect (ASD) (n: 38, (30.89%)) and ventricular septal defect (VSD) (n: 28, (22.76%)). Rheumatic heart disease (RHD) was observed in 693 (51.10%) patients, senile valvular degenerative lesions (SVDL) in 366 (26.99%), mitral valve prolapse (MVP) were detected in 297 (21.9%). Mitral insufficiency (n: 965, (71.2%)) was detected as the most frequent VHD, followed by aortic insufficiency (n: 259, (19.1%)), and tricuspid insufficiency (n: 62, (4.6%)), mitral valve stenosis (n: 46, (3.4%)) and aortic stenosis (n: 24, (1.8%)) was the least common VHD. Conclusion: In the present study, we found that HHD was the most common comorbidity, followed by VHD, HFrEF and IHD. Moreover, the most common VHD was mitral insufficiency and the most common CHD was ASD.
收起
摘要 :
Objectives: To determine the frequency of obstructive coronary artery disease in patients undergoing valvular heart disease surgery. Study Design: Cross-sectional study. Setting: Department of Cardiology, Faisalabad Institute of C...
展开
Objectives: To determine the frequency of obstructive coronary artery disease in patients undergoing valvular heart disease surgery. Study Design: Cross-sectional study. Setting: Department of Cardiology, Faisalabad Institute of Cardiology, Faisalabad. Period: Six months, from 02 February, 2017 to 01 August, 2017. Material & Methods: After taking approval from hospital ethical committee, patients coming through outpatient department who fulfilled the inclusion criteria were enrolled and informed consent was taken from them. History of smoking, diabetes mellitus, renal dysfunction, dyslipidemia, hypertension and family history of coronary artery disease was assessed. Coronary angiography was performed by senior consultant interventional cardiologist for assessing obstructive coronary artery disease as per operational definition. All the information was collected on prespecified Performa. Results: In this study, out of 140 cases of valvular heart disease (VHD), 47.14%(n=66) were between 30-50 years of age whereas 52.86%(n=74) were between 51-70 years of age, mean ±sd was calculated as 51.71 9.09 years, 57.14%(n=80) were male while 42.86%(n=60) were female, frequency of obstructive coronary artery disease in patients undergoing valvular heart surgery was recorded as 29.3% (n=41) whereas 70.7% (n=99) had no such finding. Conclusion: The frequency of obstructive coronary artery disease was (29.3%) in patients undergoing valvular heart disease surgery. However, coronary artery disease was less frequent in rheumatic as compared to degenerative heart valve disease.
收起
摘要 :
To investigate the frequencies and patterns of cardiovascular diseases (CVDs), including rheumatic and congenital heart diseases, among patients with abnormal hearts assessed by echocardiographic examination. This retrospective, d...
展开
To investigate the frequencies and patterns of cardiovascular diseases (CVDs), including rheumatic and congenital heart diseases, among patients with abnormal hearts assessed by echocardiographic examination. This retrospective, descriptive registry reviewed abnormal echocardiographic findings of 1140 patients aged 0–100?years who were admitted to the cardiology outpatient clinic at a tertiary training institution in Mogadishu. Hypertensive heart disease (HHD) (n:454, 39.8%), valvular heart disease (VHD) (n:395, 34.6%), and heart failure with reduced ejection fraction (HFrEF) (n:351, 30.8%) were the most frequent comorbidities. Congenital heart diseases (CHDs) were detected in 151 (13.2%) of the patients, with the most common ones including atrial septal defect (ASD) (n:37, 3.2%) and ventricular septal defect (VSD) (n:26, 2.3%). Rheumatic heart disease (RHD) was observed in 84 (7.4%) patients, among whom the most common age range was 16–30?years (40.5%), followed by 31–45?years (31%) and 0–15?years (15.5%). Mitral insufficiency (n:541, 47.5%) was detected as the most frequent VHD, followed by aortic insufficiency (n:437, 38.3%), and tricuspid insufficiency (n:264, 23.2%) and mitral valve stenosis (n:39, 3.4%) was the least common VHD. In the present study, we found that HHD was the most common comorbidity, followed by VHD, and HFrEF. Moreover, the most common VHD was mitral insufficiency and the most common CHD was ASD.
收起
摘要 :
About 1.35 million babies are born with congenital heart disease each year globally. Most of these are expected to lead normal, productive lives if they are treated in time. However, 90% of babies born with congenital heart diseas...
展开
About 1.35 million babies are born with congenital heart disease each year globally. Most of these are expected to lead normal, productive lives if they are treated in time. However, 90% of babies born with congenital heart disease live in regions where medical care is inadequate or unavailable. The privilege of early diagnosis and timely intervention is restricted to only those born in developed countries. Added to the burden of congenital heart disease is rheumatic heart disease, which remains a global health problem in many low-income and middle-income countries. Providing optimal care for all these children is a daunting task, and requires funds and proper planning at various levels of the health care system. This article describes the burden of pediatric heart disease, including lacunae in the current state, as well as challenges and opportunities for providing optimal care to this large population of children.
收起
摘要 :
Patients with congenital heart disease (CHD) are one of the fastest growing populations in cardiology, and valvular pathology is at the center of many congenital lesions. Derangements in valvular embryology lead to several anomali...
展开
Patients with congenital heart disease (CHD) are one of the fastest growing populations in cardiology, and valvular pathology is at the center of many congenital lesions. Derangements in valvular embryology lead to several anomalies prone to dysfunction, each with hemodynamic effects that require appropriate surveillance and management. Surgical innovation has provided new treatments that have improved survival in this population, though has also contributed to esotericism in patients who already have unique anatomic and physiologic considerations. Conduit and prosthesis durability are often monitored collaboratively with general and specialized congenital-focused cardiologists. As such, general cardiologists must become familiar with valvular disease with CHD for appropriate care and referral practices. In this review, we summarize the embryology of the semilunar and atrioventricular (AV) valves as a foundation for understanding the origins of valvular CHD and describe the mechanisms that account for heterogeneity in disease. We then highlight the categories of pathology from the simple (e.g., bicuspid aortic valve, isolated pulmonic stenosis) to the more complex (e.g., Ebstein’s anomaly, AV valvular disease in single ventricle circulations) with details on natural history, diagnosis, and contemporary therapeutic approaches. Care for CHD patients requires collaborative effort between providers, both CHD-specialized and not, to achieve optimal patient outcomes.
收起
